We are live on ! Find out more
NDRM

NeuroDerm Ltd. Ordinary Shares
NDRM

Delisted

NDRM was delisted on the 17th of October, 2017.

Back to rankings

49 hedge funds and large institutions have $149M invested in NeuroDerm Ltd. Ordinary Shares in 2015 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 13

27% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 11

20% more funds holding

Funds holding: 41 → 49 (+8)

5% less capital invested

Capital invested by funds: $158M → $149M (-$8.27M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

100% less call options, than puts

Call options by funds: $2K | Put options by funds: $2.2M

Holders
49
Holders Change
+8
Holders Change %
+19.51%
% of All Funds
1.29%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
21
Increased
14
Reduced
11
Closed
13
Calls
$2K
Puts
$2.2M
Net Calls
-$2.2M
Net Calls Change
-$3.34M

Top Buyers

Rank Fund Capital Flow
1
SCM
Scopia Capital Management
New York
+$27.4M
2
GC
GMT Capital
Georgia
+$6.55M
3
BFA
BlackRock Fund Advisors
California
+$5.17M
4
SAM
Senzar Asset Management
New York
+$2.84M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$2.55M

Top Sellers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
-$11.4M
2
CCM
Cadian Capital Management
New York
-$8.67M
3
RCM
RA Capital Management
Massachusetts
-$5.46M
4
MMH
Menora Mivtachim Holdings
Israel
-$2.27M
5
GTC
Ghost Tree Capital
New York
-$2.07M
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Scopia Capital Management
New York
$46.9M +$27.4M +1,405,497 +105%
RG
2
Redmile Group
California
$27.1M +$2.47M +126,562 +9%
GC
3
GMT Capital
Georgia
$15.4M +$6.55M +336,200 +59%
ACA
4
Avoro Capital Advisors
New York
$8.87M -$11.4M -583,071 -53%
ACP
5
Acuta Capital Partners
California
$8.14M -$377K -19,330 -4%
BBA
6
Baker Bros. Advisors
New York
$5.2M – – –
PA
7
Perceptive Advisors
New York
$4.6M – – –
BFA
8
BlackRock Fund Advisors
California
$4.52M +$5.17M +265,237 New
FCMI
9
Foresite Capital Management III
California
$4.47M +$5.1M +261,945 New
Acadian Asset Management
10
Acadian Asset Management
Massachusetts
$3.8M +$2.55M +130,941 +143%
SAM
11
Senzar Asset Management
New York
$3.44M +$2.84M +145,700 +260%
RCM
12
RA Capital Management
Massachusetts
$2.47M -$5.46M -280,329 -66%
ACH
13
ArrowMark Colorado Holdings
Colorado
$2.23M +$130K +6,682 +5%
Goldman Sachs
14
Goldman Sachs
New York
$1.49M +$1.7M +87,339 New
FHAM
15
Folger Hill Asset Management
New York
$1.12M +$1.28M +65,913 New
FCMI
16
Foresite Capital Management II
California
$951K -$409K -21,022 -27%
Morgan Stanley
17
Morgan Stanley
New York
$895K +$368K +18,910 +56%
NC
18
Nexthera Capital
New York
$818K +$935K +48,000 New
MC
19
Menta Capital
California
$809K +$568K +29,161 +159%
BIM
20
Bogle Investment Management
Massachusetts
$755K -$965K -49,548 -53%
UOC
21
UBS O'Connor
Illinois
$682K +$779K +40,000 New
Deutsche Bank
22
Deutsche Bank
Germany
$488K +$558K +28,633 New
AA
23
ALPS Advisors
Colorado
$484K -$104K -5,315 -16%
BIT
24
BlackRock Institutional Trust
California
$475K +$542K +27,837 New
QSS
25
Quantitative Systematic Strategies
Florida
$307K -$47.5K -2,440 -12%
1
2 3

NDRM Hedge Fund Activity: Q4 2015 in Review

49 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in NeuroDerm Ltd. Ordinary Shares (NDRM) for Q4 2015, worth a combined $149M — down 5.2% from $158M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new NDRM positions and 13 closed out — a net gain of 8 holders — while 14 added to existing stakes and 11 trimmed.

The largest buyer was Scopia Capital Management, adding an estimated $27.4M. The largest seller was Avoro Capital Advisors, cutting an estimated $11.4M.

  • 49 institutional investors held NeuroDerm Ltd. Ordinary Shares (NDRM) as of Q4 2015, up from 41 in Q3 2015.
  • Funds reported $149M of NeuroDerm Ltd. Ordinary Shares stock for Q4 2015, down 5.2% quarter-over-quarter.
  • 21 funds opened new NeuroDerm Ltd. Ordinary Shares positions in Q4 2015 and 13 closed out, a net change of +8 holders.
  • The largest NeuroDerm Ltd. Ordinary Shares buyer in Q4 2015 was Scopia Capital Management, an estimated $27.4M added.
  • The largest NeuroDerm Ltd. Ordinary Shares seller in Q4 2015 was Avoro Capital Advisors, an estimated $11.4M sold.

Based on aggregated 13F filings for Q4 2015.